Table I.
Case description and CD133 expression in eight NSCLC patients.
| Patient | Age, years | Gender | Tumor subtype | TNM stage | CD133 proportion, % |
|---|---|---|---|---|---|
| 1 | 73 | Male | SCC | IIA | None detected |
| 2 | 56 | Female | AdC | IIIA | 1.9 |
| 3 | 65 | Female | AdC | IIA | None detected |
| 4 | 61 | Male | AdC | IIB | 2.1 |
| 5 | 57 | Male | AdC | IIB | None detected |
| 6 | 74 | Male | AdC | IIIA | 1.3 |
| 7 | 69 | Male | SCC | IIB | None detected |
| 8 | 58 | Male | AdC | IIA | 0.8 |
TNM staging according to International Association for the Study of Lung Cancer Lung Cancer Staging Project (20). CD, cluster of differentiation; NSCLC, non-small cell lung cancer; TNM, tumor node metastasis; SCC, squamous-cell carcinoma; AdC, adenocarcinoma.